Cardinal Health, McKesson, Georgia dominates opioid trials

Published Date: 08 Mar 2023

At a trial in Georgia on Wednesday, three drug traffickers won a case brought by the family of a drug addict, accusing the company of selling drugs.

Read Full News

Latest News

Low-glutamate diet linked to brain changes and migraine relief in veterans with Gulf War Illness

Veterans with Gulf War Illness experienced significant improvement in migraine symptoms after following a diet low in glutamate, a component of flavor-enhancing food additives commonly found in processed foods, according ...

Analysis reveals imaging is overused in diagnosing and managing facial paralysis disorder Bell's palsy

A new study analyzes how imaging is used to diagnose and manage Bell's palsy, a condition that causes sudden weakness in the muscles on one side of the face, usually temporarily. Although diagnostic imaging can help rule ...

US narrows use of muscle-wasting therapy after teen deaths

The United States on Friday said it would add its most serious warning label to a gene therapy treatment for a debilitating muscle-wasting disease, and also limit its approved use.

Washington resident is infected with a different type of bird flu

A Washington state resident has bird flu, and it's a different type than what was seen in previous infections, state health officials said Friday.

Scientists document a death from a meat allergy tied to certain ticks

Researchers have reported what they believe is the first documented death from a meat allergy that can be triggered by tick bites.

Researchers to test gene therapy for rare diseases with a new FDA trial protocol

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder.

Todays Updates

Q&A: Odds of surviving cancer drop drastically when credit score dips

While past studies have explored how cancer patients' financial health influenced their risk of mortality, new research digs in deeper by zeroing in on objective data: credit scores.

Todays Updates

Q&A: Odds of surviving cancer drop drastically when credit score dips

While past studies have explored how cancer patients' financial health influenced their risk of mortality, new research digs in deeper by zeroing in on objective data: credit scores.

Latest News

Veterans with Gulf War Illness experienced significant improvement in migraine symptoms after following a diet low in glutamate, a component of flavor-enhancing food additives commonly found in processed foods, according ...

A new study analyzes how imaging is used to diagnose and manage Bell's palsy, a condition that causes sudden weakness in the muscles on one side of the face, usually temporarily. Although diagnostic imaging can help rule ...

The United States on Friday said it would add its most serious warning label to a gene therapy treatment for a debilitating muscle-wasting disease, and also limit its approved use.

A Washington state resident has bird flu, and it's a different type than what was seen in previous infections, state health officials said Friday.

Researchers have reported what they believe is the first documented death from a meat allergy that can be triggered by tick bites.

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder.

News All Time

Ethiopia investigates possible outbreak of new viral hemorrhagic fever after 8 people are infected

African health authorities on Thursday confirmed a possible outbreak of an unidentified viral hemorrhagic fever in southern Ethiopia that is under investigation after eight suspected cases were reported.

COP30 report reveals how climate change is spreading infectious diseases to new regions

Rising temperatures, changing rainfall patterns and extreme weather events create ideal conditions for pathogens and their vectors—such as mosquitoes, midges and ticks—to thrive.

Q&A: Why experts urge continued hepatitis B vaccine birth doses for newborns

In a commentary published in Gastroenterology, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth.

Two drugs that treat prostate cancer may also be effective against leukemia

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood ...

Stinky socks help replace human bait in surveys for river blindness

New research shows that it's possible to end the practice of using people as human bait to catch and test the black flies that spread river blindness (onchocerciasis). The study by international non‐profit Sightsavers in ...

Headaches affect almost a third of people worldwide

Do you have regular migraine headaches? If so, you've got a lot of company.

Strengthening tuberculosis screening in high-risk settings

Tuberculosis (TB) continues to be one of the world's leading causes of infectious disease-related illness and death. Despite being treatable, gaps in screening and diagnosis have allowed the disease to persist as a major ...

Repurposed antibiotic shows promise against central nervous system tuberculosis

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated that doxycycline, a commonly available and inexpensive antibiotic, can improve survival rates and neurological ...

Inequities in antibiotics use persist despite pandemic decline

A study by CUNY SPH doctoral student Eslam Abousamra and Distinguished Professor Luisa N. Borrell found major disparities in antibiotic use across age groups, sex, race/ethnicity, education levels, insurance status, health ...

Nature vs. nurture: Sequencing study quantifies genetic influence on human traits and diseases

Genome sequencing has been used to determine how much genes influence human characteristics including height and weight, and susceptibility to diseases like type 2 diabetes, in a study co-led by University of Queensland researchers ...

Scientists tie lupus to a virus nearly all of us carry

One of humanity's most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic lupus erythematosus (lupus), Stanford Medicine investigators and their colleagues have found.

Headache disorders affect 3 billion people worldwide, ranking sixth for health loss in 2023

Headache disorders affected almost 3 billion people worldwide in 2023—nearly one in every three people, a figure unchanged since 1990—and ranked sixth among causes of health loss, according to new research to be published ...

Clinical trial finds single-dose combination malaria treatment as effective as multi-day, multi-dose regimen

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose of a treatment that utilizes four widely available malaria drugs, according to a new study presented ...

New study reveals long-term impacts on Stevens-Johnson syndrome survivors

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) survivors encounter rare, life-threatening drug reactions and years of physical, emotional and social consequences long after leaving the hospital, according ...

Global tuberculosis diagnoses rise to a record, but deaths fall, WHO reports

The number of people diagnosed with tuberculosis worldwide rose again last year, eclipsing 2023's record total, World Health Organization officials said Wednesday.

Halting pancreatic cancer spread: Protein-degrading drugs show promise in preclinical models

Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade the oncogenic enzyme Pin1, a protein that is overexpressed in many tumors, including pancreatic ...

Recommended News For You

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

Recommended Articles For You

Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI 

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care 

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer 

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Rural residents continue to have higher odds of skin cancer, study finds

2.

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

3.

Cancer Patients Are Receiving More and More Stupid Immunotherapy.

4.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

5.

Cancer Patients' Depression May Be Helped by Psilocybin.

1.

The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure 

2.

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target

3.

The latest Hematocrit: An Overview of Red Blood Cell Health 

4.

Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL

5.

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

2.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

3.

Oropharyngeal Cancer in Relation to HPV Status

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot